Search for Clinical Trial Results

Sponsored By

Graft vs Host Disease - 25 Studies Found

Status Study
Active, not recruiting Study Name: A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
Condition: Graft vs Host Disease
Date: 2012-10-02
Interventions: Drug: Alpha-1-Antitrypsin (AAT) AAT (Zemaira) will be administered at a dose of 60mg/kg (actual weight)
Completed Study Name: Cyclosporine Implant for Ocular Graft-Versus-Host Disease
Condition: Graft Vs Host Disease
Date: 2005-01-29
Interventions: Drug: Subconjunctival Cyclosporine Implant
Recruiting Study Name: Topical Vitamin D in Acute Graft Versus Host Disease of the Skin
Condition: Graft Vs Host Disease
Date: 2017-03-23
Interventions: Dietary Supplement: Calcipotriene Topical vitamin D cream will be applied to affected areas of the skin.
Recruiting Study Name: A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Graft vs Host Disease
Date: 2015-03-01
Interventions: Biological: Donor regulatory T cell adoptive immunotherapy in chronic graft versus host disease
Completed Study Name: Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease
Condition: Graft Vs Host Disease
Date: 2002-05-06
Interventions: Drug: ABX-CBL
Terminated Study Name: A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients
Condition: Graft vs Host Disease
Date: 2013-10-23
Interventions:
  • Drug: ASEDs Experimental Inter
Completed Study Name: Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Date: 2005-08-26
Interventions: Drug: Rituximab Given once weekly for 4 weeks followed by a 4 week observation therapy.
Terminated Study Name: Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients
Condition: Graft vs Host Disease
Date: 2011-01-23
Interventions: Drug: Itraconazole 200mg bid, oral solution, until a dose of prednisone was tapered to 10mg/day in case
Completed Study Name: Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Date: 2010-01-04
Interventions: Drug: Alemtuzumab and rituximab Alemtuzumab at 10mg subcutaneously daily for 3 doses (days 1, 2 and 3) R
Completed Study Name: Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
Date: 2002-11-07
Interventions: Procedure: Extracorporeal Photopheresis
Next >>>